Ocular Therapeutix
OCUL
OCUL
69 hedge funds and large institutions have $60.1M invested in Ocular Therapeutix in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
17% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 23
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
38% less capital invested
Capital invested by funds: $96.5M → $60.1M (-$36.4M)
Holders
69
Holding in Top 10
2
Calls
$378K
Puts
$434K
Top Buyers
| 1 | +$356K | |
| 2 | +$280K | |
| 3 | +$187K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$171K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$132K |
Top Sellers
| 1 | -$6.63M | |
| 2 | -$1.36M | |
| 3 | -$926K | |
| 4 |
B
Bailard
Foster City,
California
|
-$907K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$522K |